Search
Descriptor English: Quinacrine
Descriptor Spanish: Quinacrina
Descriptor quinacrina
Entry term(s) mepacrina
Scope note: Derivado de la acridina que, en el pasado, se utilizó ampliamente como antimalárico pero que actualmente ha sido reemplazado por la cloroquina. Se ha usado como antihelmíntico y en el tratamiento de la giardiasis y efusiones malignas. Se utiliza en experimentación biológica celular como un inhibidor de la fosfolipasa A2.
Descriptor Portuguese: Quinacrina
Descriptor French: Mépacrine
Tree number(s): D03.633.300.046.250.760
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D011796
Scope note: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
Allowable Qualifiers: AA analogues et dérivés
AD administration et posologie
AE effets indésirables
AG agonistes
AI antagonistes et inhibiteurs
AN analyse
BL sang
CF liquide cérébrospinal
CH composition chimique
CL classification
CS synthèse chimique
EC économie
HI histoire
IM immunologie
IP isolement et purification
ME métabolisme
PD pharmacologie
PK pharmacocinétique
PO intoxication
RE effets des radiations
SD ressources et distribution
ST normes
TO toxicité
TU usage thérapeutique
UR urine
Pharm Action: Anticestodal Agents
Antimalarials
Antinematodal Agents
Antineoplastic Agents
Enzyme Inhibitors
Registry Number: H0C805XYDE
CAS Type 1 Name: 1,4-Pentanediamine, N4-(6-chloro-2-methoxy-9-acridinyl)-N1,N1-diethyl-
DeCS ID: 12233
Unique ID: D011796
NLM Classification: QV 258
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1960/01/01
Date of Entry: 1999/01/01
Revision Date: 2016/05/31
Mépacrine - Preferred
Concept UI M0018330
Preferred term Mépacrine



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.


Go to survey